30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

ARS Pharmaceuticals Inc (SPRY)

Track

Recent insider trading at ARS Pharmaceuticals Inc. shows a net sell-off over the last 90 days, with total sell transactions amounting to $567,100. Notably, several executives, including the Chief Commercial Officer and Chief Legal Officer, engaged in planned and proposed sales in June 2026. The company's stock has seen a 12.2% increase in the past 90 days.
Stock chart
Ticker: SPRY Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Karas Eric
Chief Commercial Officer
1 sale — total 100,000 USD
Planned sale 12 Jun 2026
Value US$4,948,124.82 | Price 410.86 | Shares 18,345
Planned sale 12 Jun 2026
Value US$588,259.83 | Price 241.13 | Shares 47,633
Proposed sale 12 Jun 2026
Value US$100,000.00 | Price 10.00 | Shares 1,000
Proposed sale 12 Jun 2026
Value US$100,000.00 | Price 10.00 | Shares 1,000
Sale 13 Nov 2025
Value US$190,049.85 | Price 8.71 | Shares 21,828
Proposed sale 13 Nov 2025
Value US$190,049.85 | Price 8.71 | Shares 21,828
Sale 12 Nov 2025
Value US$1,208,790.49 | Price 8.86 | Shares 136,380
Sale 12 Nov 2025
Value US$267,357.00 | Price 8.91 | Shares 30,000
Proposed sale 12 Nov 2025
Value US$1,227,420.00 | Price 9.00 | Shares 136,380
Proposed sale 12 Nov 2025
Value US$1,227,420.00 | Price 8.87 | Shares 138,380
Proposed sale 12 Nov 2025
Value US$267,357.00 | Price 8.91 | Shares 30,000
Planned sale 21 Aug 2025
Value US$724,345.00 | Price 14.49 | Shares 50,000
Proposed sale 21 Aug 2025
Value US$2,123,000.00 | Price 14.15 | Shares 150,000
Planned sale 21 Aug 2025
Value US$187,500.00 | Price 15.00 | Shares 12,500
Proposed sale 21 Aug 2025
Value US$187,500.00 | Price 15.00 | Shares 12,500
Planned sale 20 Aug 2025
Value US$530,625.76 | Price 14.09 | Shares 37,656
Planned sale 19 Aug 2025
Value US$173,129.54 | Price 14.03 | Shares 12,344
Proposed sale 19 Aug 2025
Value US$2,100,000.00 | Price 14.00 | Shares 150,000
Planned sale 1 Jul 2025
Value US$254,860.50 | Price 16.99 | Shares 15,000
Proposed sale 1 Jul 2025
Value US$254,859.00 | Price 16.99 | Shares 15,000
Sale 27 Jun 2025
Value US$6,831,566.04 | Price 18.46 | Shares 370,074
Sale 27 Jun 2025
Value US$6,831,584.50 | Price 18.46 | Shares 370,075
Planned sale 18 Jun 2025
Value US$240,000.00 | Price 16.00 | Shares 15,000
Proposed sale 18 Jun 2025
Value US$240,000.00 | Price 16.00 | Shares 15,000
Sale 20 May 2025
Value US$1,710,024.00 | Price 14.25 | Shares 120,000
Proposed sale 20 May 2025
Value US$1,710,000.00 | Price 14.25 | Shares 120,000
Sale 20 May 2025
Value US$705,165.00 | Price 14.10 | Shares 50,000
Proposed sale 20 May 2025
Value US$705,000.00 | Price 14.10 | Shares 50,000
Sale 20 May 2025
Value US$1,451,512.81 | Price 14.10 | Shares 102,969
Proposed sale 20 May 2025
Value US$1,443,893.78 | Price 14.02 | Shares 102,969
Planned sale 7 Apr 2025
Value US$615,074.60 | Price 12.30 | Shares 50,002
Proposed sale 7 Apr 2025
Value US$615,050.70 | Price 12.30 | Shares 50,002
Planned sale 20 Mar 2025
Value US$140,000.00 | Price 14.00 | Shares 10,000
Proposed sale 20 Mar 2025
Value US$140,000.00 | Price 14.00 | Shares 10,000
Planned sale 6 Mar 2025
Value US$556,045.76 | Price 11.21 | Shares 49,600
Planned sale 5 Mar 2025
Value US$4,400.00 | Price 11.00 | Shares 400
Proposed sale 5 Mar 2025
Value US$550,000.00 | Price 11.00 | Shares 50,000
Planned sale 3 Feb 2025
Value US$615,565.00 | Price 12.31 | Shares 50,000
Proposed sale 3 Feb 2025
Value US$615,564.59 | Price 12.31 | Shares 50,000
Planned sale 6 Jan 2025
Value US$555,065.00 | Price 11.10 | Shares 50,000
Proposed sale 6 Jan 2025
Value US$555,064.55 | Price 11.10 | Shares 50,000
Planned sale 17 Dec 2024
Value US$583,525.00 | Price 11.67 | Shares 50,000
Planned sale 17 Dec 2024
Value US$583,575.00 | Price 11.67 | Shares 50,000
Planned sale 17 Dec 2024
Value US$583,525.00 | Price 11.67 | Shares 50,000
Planned sale 17 Dec 2024
Value US$583,575.00 | Price 11.67 | Shares 50,000
Proposed sale 13 Dec 2024
Value US$328,967.35 | Price 12.06 | Shares 27,272
Sale 13 Dec 2024
Value US$328,968.50 | Price 12.06 | Shares 27,272
Sale 12 Dec 2024
Value US$307,432.50 | Price 12.30 | Shares 25,000
Sale 12 Dec 2024
Value US$1,439,124.44 | Price 12.27 | Shares 117,333
Planned sale 11 Dec 2024
Value US$186,426.00 | Price 12.43 | Shares 15,000
Proposed sale 11 Dec 2024
Value US$814,572.00 | Price 13.31 | Shares 61,200
Proposed sale 10 Dec 2024
Value US$1,349,329.50 | Price 11.50 | Shares 117,333
Sale 10 Dec 2024
Value US$657,625.00 | Price 13.15 | Shares 50,000
Proposed sale 10 Dec 2024
Value US$701,000.00 | Price 14.02 | Shares 50,000
Planned sale 10 Dec 2024
Value US$658,155.00 | Price 13.16 | Shares 50,000
Planned sale 10 Dec 2024
Value US$658,265.00 | Price 13.17 | Shares 50,000
Planned sale 10 Dec 2024
Value US$658,155.00 | Price 13.16 | Shares 50,000
Planned sale 10 Dec 2024
Value US$658,265.00 | Price 13.17 | Shares 50,000
Proposed sale 10 Dec 2024
Value US$4,020,000.00 | Price 13.40 | Shares 300,000
Proposed sale 6 Dec 2024
Value US$700,000.00 | Price 14.00 | Shares 50,000
Sale 6 Dec 2024
Value US$711,615.00 | Price 14.23 | Shares 50,000
Sale 5 Dec 2024
Value US$701,641.54 | Price 14.13 | Shares 49,640
Proposed sale 5 Dec 2024
Value US$661,204.80 | Price 13.32 | Shares 49,640
Sale 4 Dec 2024
Value US$627,943.50 | Price 13.95 | Shares 45,000
Proposed sale 4 Dec 2024
Value US$652,950.00 | Price 14.51 | Shares 45,000
Proposed sale 4 Dec 2024
Value US$87,962.00 | Price 14.00 | Shares 6,283
Planned sale 4 Dec 2024
Value US$203,109.09 | Price 13.75 | Shares 14,772
Planned sale 4 Dec 2024
Value US$87,962.00 | Price 14.00 | Shares 6,283
Planned sale 3 Dec 2024
Value US$1,166,896.60 | Price 13.26 | Shares 87,984
Sale 3 Dec 2024
Value US$593,401.50 | Price 13.19 | Shares 45,000
Proposed sale 3 Dec 2024
Value US$585,000.00 | Price 13.00 | Shares 45,000
Proposed sale 2 Dec 2024
Value US$2,713,000.00 | Price 13.57 | Shares 200,000
Planned sale 2 Dec 2024
Value US$12,921.87 | Price 14.34 | Shares 901
Planned sale 2 Dec 2024
Value US$1,305,823.39 | Price 13.55 | Shares 96,343
Planned sale 2 Dec 2024
Value US$52,461.37 | Price 14.11 | Shares 3,717
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-12 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
18,345 -1.9%
410.86
US$4,948,125 		18,345 -1.9% 410.86 US$4,948,125
2026-06-12 2026-06-12 PlS Planned sale
3.3
Fitzpatrick Alexander A

Chief Legal Officer

Officer
47,633 -21.7%
241.13
US$588,260 		47,633 -21.7% 241.13 US$588,260
2026-06-12 2026-06-12 PrS Proposed sale
ERIC KARAS

Officer

Officer
13,939
155.07
US$4,058,389 		13,939 155.07 US$4,058,389
2026-06-12 2026-06-12 PrS Proposed sale
3.3
ALEXANDER FITZPATRICK

Officer

Officer
1,000
10.00
US$100,000 		1,000 10.00 US$100,000
2025-11-14 2025-11-13 S Sale
1.9
Dorsey Brian

Chief Operating Officer

Officer
21,828 -66.9%
8.71
US$190,050 		21,828 -66.9% 8.71 US$190,050
2025-11-13 2025-11-13 PrS Proposed sale
1.9
BRIAN T DORSEY

Officer

Officer
21,828
8.71
US$190,050 		21,828 8.71 US$190,050
2025-11-14 2025-11-12 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
136,380 -100.0%
8.86
US$1,208,790 		136,380 -100.0% 8.86 US$1,208,790
2025-11-14 2025-11-12 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
30,000 -18.0%
8.91
US$267,357 		30,000 -18.0% 8.91 US$267,357
2025-11-12 2025-11-12 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
136,380
9.00
US$1,227,420 		136,380 9.00 US$1,227,420
2025-11-12 2025-11-12 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
138,380
8.87
US$1,227,420 		138,380 8.87 US$1,227,420
2025-11-12 2025-11-12 PrS Proposed sale
3.2
JUSTIN CHAKMA

Officer

Officer
30,000
8.91
US$267,357 		30,000 8.91 US$267,357
2025-08-22 2025-08-21 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.0%
14.49
US$724,345 		50,000 -4.0% 14.49 US$724,345
2025-08-22 2025-08-21 PlS Planned sale
2.8
Scott Kathleen D.

Chief Financial Officer

Officer
12,500 -55.5%
15.00
US$187,500 		12,500 -55.5% 15.00 US$187,500
2025-08-21 2025-08-21 PrS Proposed sale
2.8
KATHLEEN D SCOTT

Officer

Officer
12,500
15.00
US$187,500 		12,500 15.00 US$187,500
2025-08-21 2025-08-21 PrS Proposed sale
Lowenthal Richard E

Officer; Director; Member of immediate family of any of the foregoing

Executive Director
150,000
14.15
US$2,123,000 		150,000 14.15 US$2,123,000
2025-08-21 2025-08-20 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
37,656 -2.9%
14.09
US$530,626 		37,656 -2.9% 14.09 US$530,626
2025-08-21 2025-08-19 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
12,344 -1.0%
14.03
US$173,130 		12,344 -1.0% 14.03 US$173,130
2025-08-19 2025-08-19 PrS Proposed sale
Tanimoto Sarina

Officer; Member of immediate family of any of the foregoing

Officer
150,000
14.00
US$2,100,000 		150,000 14.00 US$2,100,000
2025-07-03 2025-07-01 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
15,000 -59.3%
16.99
US$254,860 		15,000 -59.3% 16.99 US$254,860
2025-07-01 2025-07-01 PrS Proposed sale
ERIC KARAS

Officer

Officer
15,000
16.99
US$254,859 		15,000 16.99 US$254,859
2025-07-01 2025-06-27 S Sale
2.8
Flynn James E
Large shareholder
370,074 -7.0%
18.46
US$6,831,566 		370,074 -7.0% 18.46 US$6,831,566
2025-07-01 2025-06-27 S Sale
2.8
Flynn James E
Large shareholder
370,075 -7.0%
18.46
US$6,831,584 		370,075 -7.0% 18.46 US$6,831,584
2025-06-20 2025-06-18 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
15,000 -66.1%
16.00
US$240,000 		15,000 -66.1% 16.00 US$240,000
2025-06-18 2025-06-18 PrS Proposed sale
ERIC KARAS

Officer

Officer
15,000
16.00
US$240,000 		15,000 16.00 US$240,000
2025-05-22 2025-05-20 S Sale
3.1
SAUNDERS BRENT L
Non-Executive Director
120,000 -100.0%
14.25
US$1,710,024 		120,000 -100.0% 14.25 US$1,710,024
2025-05-22 2025-05-20 S Sale
2.8
Scott Kathleen D.

Chief Financial Officer

Officer
50,000 -87.1%
14.10
US$705,165 		50,000 -87.1% 14.10 US$705,165
2025-05-22 2025-05-20 S Sale
3.3
Fitzpatrick Alexander A

Chief Legal Officer

Officer
102,969 -53.5%
14.10
US$1,451,513 		102,969 -53.5% 14.10 US$1,451,513
2025-05-20 2025-05-20 PrS Proposed sale
2.8
Scott Kathleen D.

Officer

Officer
50,000
14.10
US$705,000 		50,000 14.10 US$705,000
2025-05-20 2025-05-20 PrS Proposed sale
3.3
Fitzpatrick Alexander A

Officer

Officer
102,969
14.02
US$1,443,894 		102,969 14.02 US$1,443,894
2025-05-20 2025-05-20 PrS Proposed sale
3.1
SAUNDERS BRENT L

Director

Non-Executive Director
120,000
14.25
US$1,710,000 		120,000 14.25 US$1,710,000
2025-04-08 2025-04-07 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
50,002 -19.2%
12.30
US$615,075 		50,002 -19.2% 12.30 US$615,075
2025-04-07 2025-04-07 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,002
12.30
US$615,051 		50,002 12.30 US$615,051
2025-03-21 2025-03-20 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
10,000 -56.5%
14.00
US$140,000 		10,000 -56.5% 14.00 US$140,000
2025-03-20 2025-03-20 PrS Proposed sale
ERIC KARAS

Officer

Officer
10,000
14.00
US$140,000 		10,000 14.00 US$140,000
2025-03-07 2025-03-06 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
49,600 -19.1%
11.21
US$556,046 		49,600 -19.1% 11.21 US$556,046
2025-03-07 2025-03-05 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
400 -0.2%
11.00
US$4,400 		400 -0.2% 11.00 US$4,400
2025-03-05 2025-03-05 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,000
11.00
US$550,000 		50,000 11.00 US$550,000
2025-02-04 2025-02-03 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
50,000 -19.2%
12.31
US$615,565 		50,000 -19.2% 12.31 US$615,565
2025-02-03 2025-02-03 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,000
12.31
US$615,565 		50,000 12.31 US$615,565
2025-01-07 2025-01-06 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
50,000 -19.2%
11.10
US$555,065 		50,000 -19.2% 11.10 US$555,065
2025-01-06 2025-01-06 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,000
11.10
US$555,065 		50,000 11.10 US$555,065
2024-12-19 2024-12-17 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.4%
11.67
US$583,525 		50,000 -4.4% 11.67 US$583,525
2024-12-19 2024-12-17 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.7%
11.67
US$583,575 		50,000 -3.7% 11.67 US$583,575
2024-12-19 2024-12-17 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.4%
11.67
US$583,525 		50,000 -4.4% 11.67 US$583,525
2024-12-19 2024-12-17 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.7%
11.67
US$583,575 		50,000 -3.7% 11.67 US$583,575
2024-12-13 2024-12-13 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
27,272
12.06
US$328,967 		27,272 12.06 US$328,967
2024-12-13 2024-12-13 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
27,272 -16.7%
12.06
US$328,968 		27,272 -16.7% 12.06 US$328,968
2024-12-13 2024-12-12 S Sale
1.9
Dorsey Brian

Chief Operating Officer

Officer
25,000 -80.6%
12.30
US$307,432 		25,000 -80.6% 12.30 US$307,432
2024-12-13 2024-12-12 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
117,333 -46.2%
12.27
US$1,439,124 		117,333 -46.2% 12.27 US$1,439,124
2024-12-13 2024-12-11 PlS Planned sale
1.9
Dorsey Brian

Chief Operating Officer

Officer
15,000 -71.3%
12.43
US$186,426 		15,000 -71.3% 12.43 US$186,426
2024-12-11 2024-12-11 PrS Proposed sale
1.9
Dorsey Brian

Officer

Officer
61,200
13.31
US$814,572 		61,200 13.31 US$814,572
2024-12-12 2024-12-10 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
117,333
11.50
US$1,349,330 		117,333 11.50 US$1,349,330
2024-12-12 2024-12-10 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
50,000 -26.8%
13.15
US$657,625 		50,000 -26.8% 13.15 US$657,625
2024-12-11 2024-12-10 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.2%
13.16
US$658,155 		50,000 -4.2% 13.16 US$658,155
2024-12-11 2024-12-10 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.9%
13.17
US$658,265 		50,000 -3.9% 13.17 US$658,265
2024-12-11 2024-12-10 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.2%
13.16
US$658,155 		50,000 -4.2% 13.16 US$658,155
2024-12-11 2024-12-10 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.9%
13.17
US$658,265 		50,000 -3.9% 13.17 US$658,265
2024-12-10 2024-12-10 PrS Proposed sale
3.2
Chakma Justin

Director

Non-Executive Director
50,000
14.02
US$701,000 		50,000 14.02 US$701,000
2024-12-10 2024-12-10 PrS Proposed sale
Lowenthal Richard E

Officer; Director; Member of immediate family of any of the foregoing

Executive Director
300,000
13.40
US$4,020,000 		300,000 13.40 US$4,020,000
2024-12-06 2024-12-06 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
50,000
14.00
US$700,000 		50,000 14.00 US$700,000
2024-12-06 2024-12-06 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
50,000 -26.8%
14.23
US$711,615 		50,000 -26.8% 14.23 US$711,615
2024-12-06 2024-12-05 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
49,640 -26.7%
14.13
US$701,642 		49,640 -26.7% 14.13 US$701,642
2024-12-05 2024-12-05 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
49,640
13.32
US$661,205 		49,640 13.32 US$661,205
2024-12-06 2024-12-04 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
45,000 -24.8%
13.95
US$627,944 		45,000 -24.8% 13.95 US$627,944
2024-12-04 2024-12-04 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
45,000
14.51
US$652,950 		45,000 14.51 US$652,950
2024-12-04 2024-12-04 PrS Proposed sale
ERIC KARAS

Officer

Officer
6,283
14.00
US$87,962 		6,283 14.00 US$87,962
2024-12-04 2024-12-04 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
14,772 -6.6%
13.75
US$203,109 		14,772 -6.6% 13.75 US$203,109
2024-12-04 2024-12-04 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
6,283 -52.5%
14.00
US$87,962 		6,283 -52.5% 14.00 US$87,962
2024-12-04 2024-12-03 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
87,984 -29.5%
13.26
US$1,166,897 		87,984 -29.5% 13.26 US$1,166,897
2024-12-04 2024-12-03 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
45,000 -24.8%
13.19
US$593,402 		45,000 -24.8% 13.19 US$593,402
2024-12-03 2024-12-03 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
45,000
13.00
US$585,000 		45,000 13.00 US$585,000
2024-12-09 2024-12-02 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
200,000
13.57
US$2,713,000 		200,000 13.57 US$2,713,000
2024-12-04 2024-12-02 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
901 -0.4%
14.34
US$12,922 		901 -0.4% 14.34 US$12,922
2024-12-04 2024-12-02 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
96,343 -31.3%
13.55
US$1,305,823 		96,343 -31.3% 13.55 US$1,305,823
2024-12-04 2024-12-02 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
3,717 -39.5%
14.11
US$52,461 		3,717 -39.5% 14.11 US$52,461
Explore more

More insider trading research around ARS Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America